STOCK TITAN

[SCHEDULE 13G/A] Aveanna Healthcare Holdings, Inc. Amended Passive Investment Disclosure

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Aveanna Healthcare Holdings Inc. (AVAH) received an updated ownership report on a Schedule 13G/A. Several J.H. Whitney–affiliated entities disclosed beneficial ownership of Aveanna common stock as of 12/31/2025.

PSA Healthcare Investment Holding LLC reported beneficial ownership of 15,523,810 shares, or 7.43% of the common stock. J.H. Whitney VII, L.P. reported 19,292,787 shares, or 9.23%. PSA Iliad Holdings LLC reported 1,426,034 shares (0.68%), JHW Iliad Holdings LLC reported 3,460,515 shares (1.66%), and JHW Iliad Holdings II LLC reported 362,746 shares (0.17%).

Each reporting person has sole voting and dispositive power over its reported shares and no shared power. The J.H. Whitney entities and funds and entities advised by Bain Capital Investors, LLC are parties to a stockholders’ agreement to coordinate voting for director nominees and transfers of Aveanna common stock. Based on available information, that broader group may be deemed to beneficially own about 121,666,770 shares, or 58.24% of Aveanna’s common stock under applicable rules, though the J.H. Whitney parties expressly disclaim beneficial ownership of shares held by others.

Positive

  • None.

Negative

  • None.

Insights

Filing details concentrated control of Aveanna’s stock among sponsor groups.

The filing shows multiple J.H. Whitney entities with individual holdings between 0.17% and 9.23% of Aveanna common stock, each with sole voting and dispositive power over its shares as of 12/31/2025. Alone, these are sizeable but not majority stakes.

However, the disclosure that the J.H. Whitney entities and Bain Capital–advised funds are bound by a stockholders’ agreement is important for governance. Under this agreement they coordinate director nominations and share transfers, which regulators may treat as a Section 13(d) “group.”

The filing states this potential group would be deemed to beneficially own about 121,666,770 Aveanna shares, or roughly 58.24% of outstanding common stock under Rule 13d-3. The reporting entities specifically disclaim beneficial ownership of others’ shares, so future company filings and proxy materials will remain key to understanding how this coordination influences board composition and strategic decisions.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



PSA Healthcare Investment Holding LLC
Signature:/s/ David Zatlukal
Name/Title:Vice President
Date:02/10/2026
J.H. Whitney VII, L.P.
Signature:/s/ David Zatlukal
Name/Title:Vice President
Date:02/10/2026
PSA Iliad Holdings LLC
Signature:/s/ David Zatlukal
Name/Title:Vice President
Date:02/10/2026
JHW Iliad Holdings LLC
Signature:/s/ David Zatlukal
Name/Title:Vice President
Date:02/10/2026
JHW Iliad Holdings II LLC
Signature:/s/ David Zatlukal
Name/Title:President
Date:02/10/2026
Aveanna Healthcare Holdings, Inc.

NASDAQ:AVAH

AVAH Rankings

AVAH Latest News

AVAH Latest SEC Filings

AVAH Stock Data

1.64B
56.10M
5.67%
88.84%
2.14%
Medical Care Facilities
Services-home Health Care Services
Link
United States
ATLANTA